Marsh closes AltamarCAM acquisition, crosses $75B in private markets AUM

Marsh & McLennan completed its acquisition of AltamarCAM, the Madrid-based private markets solutions provider, pushing the insurance broker's total private markets assets under management to $75 billion. The deal, first announced in late 2024, closed without fanfare in early January and marks the clearest signal yet that distribution giants are absorbing specialist managers rather than building platforms from scratch.

AltamarCAM brought $17 billion in private markets AUM and a client roster heavy on European pension funds and sovereign wealth vehicles. Marsh already controlled roughly $58 billion in private markets exposure through Mercer, its investment consulting arm. The acquisition adds direct fund-of-funds capabilities, co-investment infrastructure, and secondary market execution—three services Mercer clients were previously sourcing from competitors. AltamarCAM's 240-person team remains intact and will operate under Mercer's private markets division. The Madrid office becomes Mercer's European private markets hub.

The timing reflects a structural shift in how institutions access private capital. Family offices and corporate pension plans no longer tolerate the two-year lag between commitment and deployment that characterized 2015-era fund-of-funds structures. They want co-investment rights, liquidity options, and managers who can execute secondaries at par during down quarters. AltamarCAM built exactly that infrastructure over fifteen years, with 78% of its AUM in evergreen or semi-liquid vehicles. Marsh paid an undisclosed sum—likely 2.5-3.0% of AUM based on comparable transactions—to avoid spending five years replicating that operational stack.

The $75 billion threshold matters because it places Marsh's private markets platform within shouting distance of StepStone ($650 billion) and Partners Group ($150 billion), though still well behind. More relevant: it positions Mercer as the only global benefits consultant with captive access to a top-fifteen private markets manager by AUM. That creates obvious conflicts but also genuine efficiency for allocators managing $500 million to $5 billion in alternatives exposure. They can now negotiate a single service agreement covering consultant advice, fund selection, and direct co-investment access. Whether that bundling proves advantageous or extractive will depend entirely on fee discipline, which Marsh has not historically demonstrated.

Allocators should watch three follow-on events. First, whether Mercer's consulting arm begins systematically steering clients toward AltamarCAM vehicles over competing fund-of-funds managers—Q2 2025 RFP seasons will be telling. Second, how quickly Marsh consolidates its private markets technology stack; AltamarCAM runs proprietary portfolio monitoring tools that don't talk to Mercer's existing systems. Third, whether the Madrid team stays beyond their likely eighteen-month retention packages. Founder turnover at 50% or higher within two years would signal integration failure and AUM leakage.

The firm is already marketing a co-investment product targeting $2 billion in commitments by year-end, structured as an evergreen vehicle with quarterly liquidity at 95% of NAV. That structure only works if Marsh can underwrite the liquidity mismatch—plausible, given the insurance balance sheet, but not guaranteed. The product launches in Q2 2025 and will serve as the clearest test of whether this acquisition was about capability or simply AUM optics.